87 related articles for article (PubMed ID: 26286895)
1. Immunoglobulin treatment in post-polio syndrome: Identification of responders and non-responders.
Östlund G; Broman L; Werhagen L; Borg K
J Rehabil Med; 2015 Sep; 47(8):727-33. PubMed ID: 26286895
[TBL] [Abstract][Full Text] [Related]
2. IVIG treatment in post-polio patients: evaluation of responders.
Ostlund G; Broman L; Werhagen L; Borg K
J Neurol; 2012 Dec; 259(12):2571-8. PubMed ID: 22592288
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial.
Gonzalez H; Sunnerhagen KS; Sjöberg I; Kaponides G; Olsson T; Borg K
Lancet Neurol; 2006 Jun; 5(6):493-500. PubMed ID: 16713921
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis.
Huang YH; Chen HC; Huang KW; Chen PC; Hu CJ; Tsai CP; Tam KW; Kuan YC
BMC Neurol; 2015 Mar; 15():39. PubMed ID: 25886512
[TBL] [Abstract][Full Text] [Related]
5. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study.
Farbu E; Rekand T; Vik-Mo E; Lygren H; Gilhus NE; Aarli JA
Eur J Neurol; 2007 Jan; 14(1):60-5. PubMed ID: 17222115
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous immunoglobulin on pain in patients with post-polio syndrome.
Werhagen L; Borg K
J Rehabil Med; 2011 Nov; 43(11):1038-40. PubMed ID: 22031351
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up.
Gonzalez H; Khademi M; Borg K; Olsson T
J Neuroinflammation; 2012 Jul; 9():167. PubMed ID: 22776106
[TBL] [Abstract][Full Text] [Related]
8. Impact of pain on quality of life in patients with post-polio syndrome.
Werhagen L; Borg K
J Rehabil Med; 2013 Feb; 45(2):161-3. PubMed ID: 23223903
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome.
Bertolasi L; Frasson E; Turri M; Gajofatto A; Bordignon M; Zanolin E; Martini M; Pimazzoni F; Ferlisi M; Zanusso G; Rossi M; Monaco S
J Neurol Sci; 2013 Jul; 330(1-2):94-9. PubMed ID: 23683859
[TBL] [Abstract][Full Text] [Related]
10. Vitality among Swedish patients with post-polio: a physiological phenomenon.
Ostlund G; Wahlin A; Sunnerhagen KS; Borg K
J Rehabil Med; 2008 Oct; 40(9):709-14. PubMed ID: 18843421
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous immunoglobulin in patients with post-polio syndrome -- an uncontrolled pilot study.
Kaponides G; Gonzalez H; Olsson T; Borg K
J Rehabil Med; 2006 Mar; 38(2):138-40. PubMed ID: 16546773
[TBL] [Abstract][Full Text] [Related]
12. [Intravenous immunoglobulin in postpolio syndrome].
Farbu E; Rekand T; Gilhus NE; Strøm V; Opheim A; Stanghelle JK; Aarli JA
Tidsskr Nor Laegeforen; 2004 Sep; 124(18):2357-8. PubMed ID: 15467799
[TBL] [Abstract][Full Text] [Related]
13. Restless legs syndrome and post polio syndrome: a case-control study.
Romigi A; Pierantozzi M; Placidi F; Evangelista E; Albanese M; Liguori C; Nazzaro M; Risina BU; Simonelli V; Izzi F; Mercuri NB; Desiato MT
Eur J Neurol; 2015 Mar; 22(3):472-8. PubMed ID: 25393503
[TBL] [Abstract][Full Text] [Related]
14. Impact of post-polio-related fatigue on quality of life.
On AY; Oncu J; Atamaz F; Durmaz B
J Rehabil Med; 2006 Sep; 38(5):329-32. PubMed ID: 16931464
[TBL] [Abstract][Full Text] [Related]
15. Effects of lamotrigine on the symptoms and life qualities of patients with post polio syndrome: a randomized, controlled study.
On AY; Oncu J; Uludag B; Ertekin C
NeuroRehabilitation; 2005; 20(4):245-51. PubMed ID: 16403993
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Intravenous Immunoglobulin for Management of Pain in Patients with Postpolio Syndrome.
Chang MC; Park JS; Hwang JM; Park D
Pain Res Manag; 2021; 2021():6637705. PubMed ID: 33824690
[TBL] [Abstract][Full Text] [Related]
17. An open trial of pyridostigmine in post-poliomyelitis syndrome.
Trojan DA; Cashman NR
Can J Neurol Sci; 1995 Aug; 22(3):223-7. PubMed ID: 8529175
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome.
Stein DP; Dambrosia JM; Dalakas MC
Ann N Y Acad Sci; 1995 May; 753():296-302. PubMed ID: 7611638
[TBL] [Abstract][Full Text] [Related]
19. Transcranial direct current stimulation (tDCS) for sleep disturbances and fatigue in patients with post-polio syndrome.
Acler M; Bocci T; Valenti D; Turri M; Priori A; Bertolasi L
Restor Neurol Neurosci; 2013; 31(5):661-8. PubMed ID: 23863351
[TBL] [Abstract][Full Text] [Related]
20. Post polio syndrome: fatigued patients a specific subgroup?
Östlund G; Wahlin Å; Sunnerhagen KS; Borg K
J Rehabil Med; 2011 Jan; 43(1):39-45. PubMed ID: 21174052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
